GLP-1 drugs like Ozempic and Zepbound are transforming obesity treatment, yet 40-85% of patients are plagued by adverse GI eventsparticularly women
Many, including the supplement Konzier took, feature the plant-derived compound berberine, also called natures Ozempic. Some studies have found berberine can increase GLP-1 production in rats, and potentially drive moderate weight loss in humans, but researchers have called for more conclusive evidence
For a large portion of the population, that was always going to be a dealbreaker
Both formulas are incredibly lightweight, non-sticky, and gentle on the skin
Our editorial team views this as Belles single most important competitive advantage
The opportunity The data points to a major expansion opportunity for oral GLP-1s in the UK market, particularly among younger adults and treatment-hesitant patients